This research demonstrates dietary mushroom supplementation influencing anxiety-like behaviors and stress coping, indicating its potential in mental health treatments.
Background Preclinical studies have demonstrated that the edible arboreal medicinal mushroom Hericium erinaceus (HE) mitigates high corticosterone levels and enhances stress-coping strategies in rodents, with emerging evidence suggesting similar neuroprotective potential for Fomitopsis officinalis (FO) and Pleurotus djamor (PDJ). However, comparative dose-dependent effects, including comprehensive anxiety and depression assessments, remain underexplored. Purpose This study investigates the dose-dependent effects of dietary supplementation with HE, FO, or PDJ on anxiety-like behaviors and stress-coping strategies in rats, building on prior findings of their anxiolytic and antidepressant-like properties, and compares these effects to fluoxetine (FLX; 20 mg/kg), a standard treatment for stress-related psychiatric disorders. Study design Male Wistar rats received 0, 100, 250, or 500 mg/kg (per os) of HE, FO, or PDJ lyophilizate from in vitro cultures for 3 weeks. Methods Behavioral outcomes were assessed using the open field test (OFT), elevated plus maze (EPM), and forced swim test (FST). Pearson’s correlations explored relationships between FST parameters. Results A middle dose of FO (250 mg/kg) increased rearing in the OFT, indicating reduced anxiety-like behavior. In the EPM, FO (100–250 mg/kg) and PDJ (100 mg/kg) increased open arm entries and time while reducing closed arm time, indicating anxiolytic-like effects consistent with prior studies on HE and extending novel insights to PDJ. In the FST, FO (250 mg/kg) reduced immobility, increased swimming, and decreased climbing, suggesting serotonergic-mediated antidepressant-like effects comparable or superior to FLX. HE and PDJ (250–500 mg/kg) reduced immobility and increased climbing or swimming, indicating dose-specific antidepressant effects. Immobility was strongly negatively correlated with swimming (r = −0.75, P < .0001) and moderately with climbing (r = −0.43, P < .001), with no significant correlation between swimming and climbing (r = −0.18, P = .06). Conclusion This study advances prior research by demonstrating that dietary supplementation with HE, FO, and PDJ exerts dose-dependent anxiolytic and antidepressant-like effects in rats, likely via serotonergic, noradrenergic, GABAergic, and anti-inflammatory pathways. The FST correlations highlight distinct coping mechanisms, supporting their potential as dietary interventions for stress-related disorders, comparable to FLX, warranting further investigation into underlying mechanisms and clinical applicability.
No takes yet. Share an insight, caveat, or question.
Trofimiuk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: